NCT00221078View on ClinicalTrials.gov

Benefits of Applying Neuroprosthesis for Improving Reaching and Grasping Functions in Stroke Patients

PHASE3CompletedINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

April 30, 2003

Primary Completion Date

June 30, 2005

Study Completion Date

December 31, 2005

Conditions
Stroke
Interventions
DEVICE

Neuroprosthesis

The Compex Motion neuroprosthesis, developed by Drs.R. Popovic and Thierry Keller, and company Compex SA, is a flexible device designed to improve grasping function in both SCI and stroke patients. This multi-channel surface stimulation system for grasping provides both palmar and lateral grasp, and holds a number of advantages over the other existing neuroprostesis.

Trial Locations (1)

M5G 2A2

Toronto Rehabilitation Institute, Toronto

All Listed Sponsors
collaborator

The Physicians' Services Incorporated Foundation

OTHER

lead

Toronto Rehabilitation Institute

OTHER

NCT00221078 - Benefits of Applying Neuroprosthesis for Improving Reaching and Grasping Functions in Stroke Patients | Biotech Hunter | Biotech Hunter